BNTX BioNTech Pharma: Net earnings per share for the last 12 months

Public company logo of BioNTech Inc. (BNTX)

BioNTech SE (BNTX) is transforming its accumulated resources into the development of mRNA cancer therapies. Unique patents and stringent FDA oversight create significant barriers to entry. The net income per share YoY ttm growth rate confirms this trend, with the latest figure standing at -160.60. However, revenue volatility and dependence on trial outcomes make future cash flows difficult to predict.

BNTX BioNTech Inc. Earnings per share for the last twelve months (02/11/2024 - 11/12/2026)

BioNTech Group - analytical breakdowns and key metrics (BNTX)

- market value and analyst target forecast:
Stock Quotes biontech.de|BNTX - Price Target Chart
- company stock capitalization data:
Market Valuation BioNTech Inc.|BNTX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share BioNTech|BNTX - Company Book Value|Capitalization to Book Value Ratio biontech.de|BNTX - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital BioNTech SE|BNTX - Long-Term Debt to Capital|Short-Term Debt to Equity BioNTech Pharma|BNTX - Company Aggregate Debts|Debts to Net Assets BioNTech Inc.|BNTX - Company Long-Term Debt|Short-Term Debt BioNTech|Immediate Liquidity Ratio biontech.de
- earnings and multiples data:
BNTX - Net Income|Future Net Profit BioNTech SE|BNTX - P/E Multiple|Projected Price to Earnings Ratio BioNTech Inc.|BNTX - PEG Multiple|Enterprise Value to EBITDA Ratio BioNTech Inc.|BNTX - Operating profit EBITDA|Earnings per share for the trailing year BioNTech|BNTX - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months biontech.de|BNTX - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year BioNTech SE
Fundamental company valuation:BNTX (biontech.de)
Core merchandise of BioNTech Pharma

BioNTech SE (BNTX) focuses on innovative developments in oncology, aiming to create new market niches. This metric measures the percentage change in earnings per share over a rolling year, assessing the growth rate of real income. Investors use this indicator to determine business sustainability in the absence of pricing power over products. An analysis of the TTM net income per share annual trend reveals the risk of capital burn in the absence of commercial levers.

Competitor analysis

argenx.com (ARGX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|Aurinia Pharma - Net earnings per share (EPS TTM)|BCRX: Earnings per share for the last twelve months|VERA: Net earnings per share (EPS TTM)|DNTH - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pharvaris|Net earnings per one share for the last twelve months AbCellera Biologics Inc ABCL|Earnings per share for the last twelve months Tourmaline Corp (TRML)|Precigen Corp - Earnings per share for the last 12 months|Pharming Group N.V. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters NKTR (nektar.com)|Upstream Bio - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Zenas Bio|IMNM: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Gossamer Bio Corp.|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|SEPN: Earnings per share for the trailing year|Net earnings per share for the last 12 months PVLA (Pieris Pharmaceuticals, Inc.)|SVRA (Savara Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Rigel Pharmaceuticals Inc RIGL|Net earnings per share for the last four quarters AnaptysBio Inc. (ANAB)|Astria Therapeutics - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months engene.com|RAPT: Net earnings per share (EPS TTM)|JBIO (Aerovate Therapeutics) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Aclaris|Earnings per share for the last 12 months KYTX (Kyverna Therapeutics, Inc)|Net earnings per share for the last 12 months TLSA (Tiziana Life Sciences)|Earnings per share for the last four quarters CABA|Ventyx Biosciences, Inc. - Net earnings per share for the last 12 months|THTX: Earnings per share for the last 12 months|AVTX - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ELDN|AGEN: Net earnings per share (EPS TTM)|climbbio.com - Earnings per share for the trailing year|ZURA (Zura Bio Limited) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) aTyr Pharma Inc|Earnings per share for the last twelve months Adagene (ADAG)|IMA (ikenaoncology.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Shattuck Labs STTK|EQ - Net earnings per share for the last 12 months|Connect Pharma - Net earnings per share (EPS TTM)|IMUX - Net earnings per share (EPS TTM)|ATRA (atarabio.com) - Net earnings per share for the last 12 months|InflaRx - Earnings per share for the trailing year|XFOR (X4 Pharmaceuticals) - Net earnings per share (EPS TTM)|Adicet (ACET) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Celularity Inc. (CELU)|Net earnings per share for the last 12 months INmune Bio Inc INMB|Earnings per share for the last twelve months Barinthus Bio BRNS|KZR - Net earnings per share for the last 12 months|SABS: Net earnings per share for the last 12 months|AKTX - Net earnings per share (EPS TTM)|enlivex.com (ENLV) - Earnings per share for the last twelve months|Earnings per share for the last 12 months QTTB|GOVX (GeoVax Labs Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Edesa Biotech Corp EDSA|Net earnings per share (EPS TTM) IBIO|Earnings per share for the last twelve months CARM (carismatx.com)|Net earnings per share (EPS TTM) XTLB (XTL Biopharmaceuticals Ltd.)|Net earnings per share for the last four quarters Bolt Biotherapeutics Inc. (BOLT)|HCWB - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Aptevo Therapeutics|AIM ImmunoTech (AIM) - Earnings per share for the last twelve months|Earnings per share for the last 12 months ADTX|Net earnings per share for the last 12 months GRI|XRTX (XORTX Therapeutics Inc) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) HIND|REVB - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) INDP (Indaptus Therapeutics)|SCNI - Net earnings per share for the last 12 months|CalciMedica Corp - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AFMD (Affimed)|ALLK (allakos.com) - Net earnings per share for the last 12 months|HOOKIPA Pharma - Earnings per share for the trailing year|Earnings per share for the last twelve months IGM Biosciences Inc.|iteostherapeutics.com (ITOS) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) OCEA|TCBP - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) THRD (Third Harmonic Bio, Inc)